ANDREW SKINNER: Open Payments
NPI 1578594826 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 16 payments from 10 companies in 2025. Trend: 2023 $1,641 · 2024 $491 · 2025 $626
Consulting: $350Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $200 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Neos Therapeutics, LP | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Corium, LLC | 1 | $17 |
Products named: SPRAVATO, XYWAV, CAPLYTA, UZEDY, ABILIFY MAINTENA, Adzenys XR-ODT, ERZOFRI EXTENDED-RELEASE, INGREZZA.
Industry payments across IN — which companies pay providers there.
